SCHEMBL11068665

SCHEMBL11068665

CCc1nc(NC(=O)NC)ccc1-c1ccnc(C)c1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.42
MAPK1 P28482 4/20 0.42
WNT3A P56704 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11065275 0.83 ADORA2B (0.45) ABL1
SCHEMBL11073568 0.77 POLB (0.42) ABL1
SCHEMBL11069334 0.74 MTOR (0.55)
SCHEMBL11066718 0.73 ADORA2B (0.44) ABL1
SCHEMBL7270939 0.73 MTOR (0.45)
SCHEMBL11069278 0.72 ADORA2B (0.43) ABL1
SCHEMBL11071690 0.72 ADORA2B (0.42) ABL1
SCHEMBL11070623 0.72 ADORA2B (0.42) ABL1
SCHEMBL7272778 0.71 DYRK1A (0.45)
SCHEMBL7968533 0.71 PSEN1 (0.66) WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4448780-A N-(Lower-alkyl)-N'-[5-(pyridinyl)-2-pyridinyl]ureas and cardiotonic use thereof STERLING DRUG INC. (US) 1984-05-15 US disclosed